CY1118913T1 - Νεοι ανθελονοσιακοι παραγοντες - Google Patents

Νεοι ανθελονοσιακοι παραγοντες

Info

Publication number
CY1118913T1
CY1118913T1 CY20171100508T CY171100508T CY1118913T1 CY 1118913 T1 CY1118913 T1 CY 1118913T1 CY 20171100508 T CY20171100508 T CY 20171100508T CY 171100508 T CY171100508 T CY 171100508T CY 1118913 T1 CY1118913 T1 CY 1118913T1
Authority
CY
Cyprus
Prior art keywords
antelonosic
factors
new
relates
present
Prior art date
Application number
CY20171100508T
Other languages
English (en)
Inventor
Jeremy Burrows
Matthew Wyvratt
Akhil Vaidya
Sandhya Kortagere
Erkang Fan
Arnab Kumar Chatterjee
Advait Suresh Nagle
Tomoyo Kato
Original Assignee
Mmv Medicines For Malaria Venture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mmv Medicines For Malaria Venture filed Critical Mmv Medicines For Malaria Venture
Publication of CY1118913T1 publication Critical patent/CY1118913T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση αφορά στην χρήση παραγώγων πυραζολίου στην βιομηχανική κατασκευή ενός φαρμάκου για αποτροπή ή θεραπεία ελονοσίας. Ειδικώς, η παρούσα εφεύρεση αφορά σε παράγωγα πυραζολίου χρήσιμα για την παρασκευή μιας φαρμακοτεχνικής μορφής για την αναστολή πολλαπλασιασμού παρασίτου ελονοσίας.
CY20171100508T 2013-07-17 2017-05-12 Νεοι ανθελονοσιακοι παραγοντες CY1118913T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361847185P 2013-07-17 2013-07-17
PCT/IB2014/063180 WO2015008246A1 (en) 2013-07-17 2014-07-17 New anti-malarial agents

Publications (1)

Publication Number Publication Date
CY1118913T1 true CY1118913T1 (el) 2018-01-10

Family

ID=51492402

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20171100508T CY1118913T1 (el) 2013-07-17 2017-05-12 Νεοι ανθελονοσιακοι παραγοντες

Country Status (17)

Country Link
US (1) US9464057B2 (el)
EP (1) EP3022200B1 (el)
JP (1) JP2016527228A (el)
CN (1) CN105377838A (el)
CA (1) CA2918290A1 (el)
CY (1) CY1118913T1 (el)
ES (1) ES2625160T3 (el)
HK (1) HK1219728A1 (el)
HR (1) HRP20170773T1 (el)
HU (1) HUE033124T2 (el)
LT (1) LT3022200T (el)
ME (1) ME02724B (el)
PL (1) PL3022200T3 (el)
PT (1) PT3022200T (el)
RS (1) RS55998B1 (el)
SI (1) SI3022200T1 (el)
WO (1) WO2015008246A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107149604A (zh) * 2017-03-17 2017-09-12 高雪亚 一种治疗非酒精性脂肪肝的药物组合物
PL233259B1 (pl) * 2017-07-10 2019-09-30 Politechnika Poznanska Indolilooctany 1-alkilochininy, sposób ich otrzymywania oraz zastosowanie jako środki bakteriostatyczne i bakteriobójcze
US11680161B2 (en) 2017-11-13 2023-06-20 Ineos Styrolution Group Gmbh Thermoplastic molding composition and articles made thereof having improved surface quality

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8486987B2 (en) 2007-11-16 2013-07-16 University Of Medicine And Dentistry Of New Jersey Mechanism-based small-molecule parasite inhibitors

Also Published As

Publication number Publication date
CA2918290A1 (en) 2015-01-22
EP3022200B1 (en) 2017-03-01
HRP20170773T1 (hr) 2017-08-11
EP3022200A1 (en) 2016-05-25
HUE033124T2 (en) 2017-11-28
ES2625160T3 (es) 2017-07-18
PT3022200T (pt) 2017-06-12
HK1219728A1 (zh) 2017-04-13
CN105377838A (zh) 2016-03-02
PL3022200T3 (pl) 2017-08-31
US20160194286A1 (en) 2016-07-07
US9464057B2 (en) 2016-10-11
ME02724B (me) 2017-10-20
WO2015008246A1 (en) 2015-01-22
SI3022200T1 (sl) 2017-06-30
RS55998B1 (sr) 2017-09-29
LT3022200T (lt) 2017-06-12
JP2016527228A (ja) 2016-09-08

Similar Documents

Publication Publication Date Title
CY1124311T1 (el) Παρεμποδιστες dna-pk
CY1123953T1 (el) Καθυστερημενης απελευθερωσης συνθεσεις λινακλοτιδης
CY1120730T1 (el) Απο του στοματος χορηγουμενη δοσολογια ενωσεων glp-1
CY1122329T1 (el) Anti-siglec-8 αντισωματα και μeθοδοι χρhσεως αυτων
CY1119566T1 (el) Αντιϊικες ενωσεις rsv
CY1120635T1 (el) Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
CY1118478T1 (el) Παραγωγα τυπου αζαϊνδαζολιου ή διαζαϊνδαζολιου για τη θεραπεια του πονου
EA201691594A1 (ru) Циклопропиламины в качестве ингибиторов lsd1
CY1118074T1 (el) Ανθελονοσιακοι παραγοντες
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
SG10201806849WA (en) Cyclopropylamines as lsd1 inhibitors
UY34750A (es) ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?.
UY34772A (es) ?una formulación de fármaco de liberación retardada?.
CY1120204T1 (el) Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο
MX2015014298A (es) Compuestos de dihidropirido pirimidina como inhibidores de autotaxina.
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
CY1122313T1 (el) Ορβεπιταντη για την αγωγη του χρονιου κνησμου
EA201691481A1 (ru) ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ
EA201590552A1 (ru) Аминохинолины в качестве ингибиторов киназы
EA201791174A1 (ru) Антимикотическое соединение
PH12018501709A1 (en) Naphthridinedione derivatives
MX2015008829A (es) Momelotinib deuterado.
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы